These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 28545803)

  • 1. Impact of a Multidisciplinary Heart Failure Postdischarge Management Clinic on Medication Adherence.
    Lu L; Jackevicius CA; de Leon NK; Warner AL; Chang DS; Mody FV
    Clin Ther; 2017 Jun; 39(6):1200-1209. PubMed ID: 28545803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Adherence to Renin-Angiotensin System Inhibitors and β-Blockers After Heart Failure Hospitalization in Senior Patients.
    Qin X; Hung J; Teng TK; Briffa T; Sanfilippo FM
    J Cardiovasc Pharmacol Ther; 2020 Nov; 25(6):531-540. PubMed ID: 32500739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment Initiation Patterns, Modifications, and Medication Adherence Among Newly Diagnosed Heart Failure Patients: A Retrospective Claims Database Analysis.
    Deschaseaux C; McSharry M; Hudson E; Agrawal R; Turner SJ
    J Manag Care Spec Pharm; 2016 May; 22(5):561-71. PubMed ID: 27123917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment prescription, adherence, and persistence after the first hospitalization for heart failure: A population-based retrospective study on 100785 patients.
    Scalvini S; Bernocchi P; Villa S; Paganoni AM; La Rovere MT; Frigerio M
    Int J Cardiol; 2021 May; 330():106-111. PubMed ID: 33582198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in adherence to evidence-based medications in the first year after initial hospitalization for heart failure: observational cohort study from 1994 to 2003.
    Lamb DA; Eurich DT; McAlister FA; Tsuyuki RT; Semchuk WM; Wilson TW; Blackburn DF
    Circ Cardiovasc Qual Outcomes; 2009 May; 2(3):228-35. PubMed ID: 20031842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cardiologist care on 6-month outcomes in patients discharged with heart failure: results from an observational study based on administrative data.
    Avaldi VM; Lenzi J; Urbinati S; Molinazzi D; Descovich C; Campagna A; Taglioni M; Fioritti A; Fantini MP
    BMJ Open; 2017 Nov; 7(11):e018243. PubMed ID: 29101146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart failure medications prescribed at discharge for patients with left ventricular assist devices.
    Shreibati JB; Sheng S; Fonarow GC; DeVore AD; Yancy CW; Bhatt DL; Schulte P; Peterson ED; Hernandez A; Heidenreich PA
    Am Heart J; 2016 Sep; 179():99-106. PubMed ID: 27595684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based pharmacotherapies used in the postdischarge phase are associated with improved one-year survival in senior patients hospitalized with heart failure.
    Qin X; Hung J; Knuiman M; Teng TK; Briffa T; Sanfilippo FM
    Cardiovasc Ther; 2018 Dec; 36(6):e12464. PubMed ID: 30126048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based medication adherence among seniors in the first year after heart failure hospitalisation and subsequent long-term outcomes: a restricted cubic spline analysis of adherence-outcome relationships.
    Qin X; Hung J; Knuiman MW; Briffa TG; Teng TK; Sanfilippo FM
    Eur J Clin Pharmacol; 2023 Apr; 79(4):553-567. PubMed ID: 36853386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence and persistence to pharmacotherapy in patients with heart failure: a nationwide cohort study, 2014-2020.
    Ødegaard KM; Lirhus SS; Melberg HO; Hallén J; Halvorsen S
    ESC Heart Fail; 2023 Feb; 10(1):405-415. PubMed ID: 36266969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment Patterns, Outcomes, and Persistence to Newly Started Heart Failure Medications in Patients with Worsening Heart Failure: A Cohort Study from the United States and Germany.
    Michel A; Lecomte C; Ohlmeier C; Raad H; Basedow F; Haeckl D; Beier D; Evers T
    Am J Cardiovasc Drugs; 2024 May; 24(3):409-418. PubMed ID: 38573461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between visit frequency, continuity of care, and pharmacy fill adherence in heart failure patients.
    Hamo CE; Mukhopadhyay A; Li X; Zheng Y; Kronish IM; Chunara R; Dodson J; Adhikari S; Blecker S
    Am Heart J; 2024 Jul; 273():53-60. PubMed ID: 38621576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to heart failure management medications following cardiac resynchronization therapy.
    Shah BR; DerSarkissian M; Tsintzos SI; Xiao Y; May D; Lu X; Kinrich D; Davis E; Lefebvre P; Duh MS; Dasta JF
    Curr Med Res Opin; 2020 Feb; 36(2):199-207. PubMed ID: 31535559
    [No Abstract]   [Full Text] [Related]  

  • 16. Real-World Analysis of Guideline-Based Therapy After Hospitalization for Heart Failure.
    Wirtz HS; Sheer R; Honarpour N; Casebeer AW; Simmons JD; Kurtz CE; Pasquale MK; Globe G
    J Am Heart Assoc; 2020 Aug; 9(16):e015042. PubMed ID: 32805181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National Trends in Hospital Performance in Guideline-Recommended Pharmacologic Treatment for Heart Failure at Discharge.
    Hess PL; Langner P; Heidenreich PA; Essien U; Leonard C; Swat SA; Polsinelli V; Orlando ST; Grunwald GK; Ho PM
    JACC Heart Fail; 2024 Jun; 12(6):1059-1070. PubMed ID: 38573268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy modifications during hospitalization in patients with chronic heart failure.
    Detiček A; Locatelli I; Roblek T; Mrhar A; Lainscak M
    Eur J Intern Med; 2016 Apr; 29():52-8. PubMed ID: 26775137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initiation and continuation of pharmacological therapies in patients hospitalized for heart failure in Japan.
    Okami S; Lecomte C; Raad H; Aguila M; Mohrova Z; Takeichi M; Tsuchiya T; Ohlmeier C; Evers T; Michel A
    Sci Rep; 2024 Apr; 14(1):9095. PubMed ID: 38643208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart failure clinics improve use of evidence-based heart failure therapies in patients with reduced ejection fraction following acute coronary syndrome (ANZACS-QI 48).
    Chan D; Doughty RN; Mazengarb J; McLachlan A; Kerr AJ
    N Z Med J; 2020 Jun; 133(1516):58-71. PubMed ID: 32525862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.